Megamox Es /5 Susp. 642.9 Mg 100 ml

Megamox Es /5 Susp. 642.9 Mg 100 ml

Description:

Megamox ES 642.9 mg suspension 100 ml is a prescription oral antibiotic medicine containing amoxicillin and clavulanic acid, manufactured by Hikma Pharma. It is a high-strength extended-spectrum (ES) amoxicillin–clavulanate suspension formulated especially for the treatment of moderate to severe bacterial infections in children and adults who require liquid dosage forms. Megamox ES works by killing susceptible bacteria and inhibiting beta-lactamase enzymes, helping to treat resistant infections of the respiratory tract, ear, sinuses, skin, and urinary tract. This product is used under medical supervision to ensure correct dose, duration, and safety.

Indications:

• Lower respiratory tract infections, including bronchitis and pneumonia, caused by beta-lactamase–producing isolates of Haemophilus influenzae and Moraxella catarrhalis.
• Acute bacterial otitis media (middle ear infection) caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Acute bacterial sinusitis caused by beta-lactamase–producing isolates of H. influenzae and M. catarrhalis.
• Skin and skin structure infections caused by beta-lactamase–producing isolates of Staphylococcus aureus, Escherichia coli, and Klebsiella species.
• Urinary tract infections (UTIs) caused by beta-lactamase–producing isolates of E. coli, Klebsiella species, and Enterobacter species.
• Other susceptible infections as determined by the physician and confirmed or strongly suspected to be caused by bacteria sensitive to amoxicillin–clavulanic acid.
• Symptoms addressed may include fever, cough with sputum, ear pain, sinus pain and congestion, painful urination, urinary frequency, and inflamed or infected skin lesions.

Active Ingredients / Key Components:

• Amoxicillin (as amoxicillin trihydrate) – exact concentration per 5 ml in this ES 642.9 mg/5 ml suspension is not specified in the available data.
• Clavulanic acid (as potassium clavulanate) – exact concentration per 5 ml in this ES 642.9 mg/5 ml suspension is not specified in the available data.
• Total labeled strength: 642.9 mg per 5 ml (exact distribution between amoxicillin and clavulanic acid is not provided in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).
• Other excipients: full list of inactive ingredients (such as sweeteners, suspending agents, flavorings, preservatives) is not available in the provided data. Please refer to the package leaflet for complete composition.

Dosage & Administration / How to Use:

• Megamox ES suspension is for oral use only and must be used exactly as prescribed by the physician.
• Shake the bottle well before each use to ensure uniform suspension.
• Use the provided measuring syringe or spoon to measure the prescribed dose accurately. Do not use household teaspoons.
• Recommended dose: depends on body weight, age, type, and severity of infection. The treating doctor will determine the mg/kg/day dose and dosing interval (usually every 12 hours). Exact dosing schedule for this specific ES 642.9 mg/5 ml strength is not provided in the available data and must be taken from the official prescribing information.
• Administration with food: it is generally recommended to take amoxicillin–clavulanic acid preparations at the start of a meal to improve absorption and reduce gastrointestinal side effects. Follow your doctor’s instructions.
• Duration of treatment: usually 5–14 days depending on the infection. Do not stop treatment early even if symptoms improve, unless advised by your doctor, to avoid relapse and antibiotic resistance.
• If a dose is missed: take it as soon as you remember, unless it is almost time for the next dose. Do not double the dose to make up for a missed one.
• Not to be used without medical supervision in children; dosing must be weight-based and determined by a pediatrician.

Clinical Benefits:

• Broad-spectrum antibacterial activity against many gram-positive and gram-negative organisms, including beta-lactamase–producing strains.
• Combination of amoxicillin with clavulanic acid helps overcome resistance by inhibiting beta-lactamase enzymes that can inactivate amoxicillin.
• Effective in treating common community-acquired infections such as otitis media, sinusitis, and lower respiratory tract infections.
• Liquid suspension form facilitates dosing in children and adults who have difficulty swallowing tablets.
• Helps relieve infection-related symptoms such as fever, pain, cough with sputum, and urinary discomfort when used appropriately.

Warnings & Contraindications:

• Contraindicated in patients with a known hypersensitivity (allergy) to amoxicillin, clavulanic acid, other penicillins, or any component of the formulation.
• Cross-sensitivity may occur in patients allergic to other beta-lactam antibiotics (e.g., cephalosporins, carbapenems); use with caution and only under medical supervision.
• History of cholestatic jaundice or hepatic dysfunction associated with amoxicillin–clavulanate use is a contraindication to re-use.
• Use with caution in patients with liver impairment or kidney impairment; dose adjustment may be required. Physician monitoring is recommended.
• Antibiotic-associated colitis (including Clostridioides difficile–associated diarrhea) may occur; persistent or severe diarrhea should be evaluated promptly.
• May interfere with some laboratory tests (e.g., urine glucose tests using non-enzymatic methods); inform healthcare providers you are taking this medicine.
• Consult your doctor before use if pregnant or nursing; amoxicillin–clavulanic acid crosses the placenta and is excreted in breast milk. Use only if clearly needed and prescribed.
• Inform your doctor about all medications you are taking, especially anticoagulants (e.g., warfarin), allopurinol, methotrexate, or other antibiotics, as interactions may occur.
• Not intended to diagnose, treat, cure, or prevent any disease without a doctor’s prescription and supervision.
• Keep out of reach of children. Accidental overdose may cause serious adverse effects and requires immediate medical attention.

Side Effects:

• Common side effects: nausea, vomiting, diarrhea, abdominal discomfort, soft stools, and mild skin rash.
• Less common side effects: headache, dizziness, oral or vaginal candidiasis (thrush), changes in taste.
• Serious side effects (seek immediate medical attention): severe allergic reactions such as rash, itching, swelling of face or throat, difficulty breathing, severe skin reactions, extensive peeling or blistering; persistent or bloody diarrhea; yellowing of the skin or eyes (jaundice); dark urine; severe abdominal pain; unusual bruising or bleeding.
• If any side effect is severe, persistent, or worrying, stop the medicine and contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Specific storage conditions (such as temperature range and shelf life after reconstitution) for Megamox ES 642.9 mg/5 ml suspension are not provided in the available data; please refer to the package leaflet. In general, many antibiotic suspensions require refrigeration after reconstitution and must be discarded after a limited number of days as indicated on the label.

Specifications:

• Product type: Prescription antibiotic medicine (oral suspension).
• Strength: 642.9 mg per 5 ml (combined amoxicillin + clavulanic acid; exact ratio not specified in available information).
• Volume: 100 ml oral suspension after reconstitution (as indicated in the product name).
• Intended users: Adults and children as prescribed by a healthcare professional.
• Route of administration: Oral.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.